Logo image of DSS

DSS INC (DSS) Stock Fundamental Analysis

NYSEARCA:DSS - NYSE Arca - US26253C2017 - Common Stock - Currency: USD

0.999  +0.02 (+2.39%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to DSS. DSS was compared to 83 industry peers in the Commercial Services & Supplies industry. Both the profitability and financial health of DSS have multiple concerns. DSS does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year DSS has reported negative net income.
In the past year DSS has reported a negative cash flow from operations.
DSS had negative earnings in 4 of the past 5 years.
In the past 5 years DSS always reported negative operating cash flow.
DSS Yearly Net Income VS EBIT VS OCF VS FCFDSS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M -80M

1.2 Ratios

DSS has a Return On Assets of -44.06%. This is amonst the worse of the industry: DSS underperforms 89.16% of its industry peers.
The Return On Equity of DSS (-231.73%) is worse than 87.95% of its industry peers.
Industry RankSector Rank
ROA -44.06%
ROE -231.73%
ROIC N/A
ROA(3y)-40.24%
ROA(5y)-26.07%
ROE(3y)-135.15%
ROE(5y)-84.67%
ROIC(3y)N/A
ROIC(5y)N/A
DSS Yearly ROA, ROE, ROICDSS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for DSS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
DSS Yearly Profit, Operating, Gross MarginsDSS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200

More info and screens

1

2. Health

2.1 Basic Checks

DSS does not have a ROIC to compare to the WACC, probably because it is not profitable.
DSS has more shares outstanding than it did 1 year ago.
The number of shares outstanding for DSS has been increased compared to 5 years ago.
Compared to 1 year ago, DSS has an improved debt to assets ratio.
DSS Yearly Shares OutstandingDSS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
DSS Yearly Total Debt VS Total AssetsDSS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

Based on the Altman-Z score of -4.29, we must say that DSS is in the distress zone and has some risk of bankruptcy.
DSS has a Altman-Z score of -4.29. This is amonst the worse of the industry: DSS underperforms 89.16% of its industry peers.
DSS has a Debt/Equity ratio of 0.12. This is a healthy value indicating a solid balance between debt and equity.
DSS has a better Debt to Equity ratio (0.12) than 73.49% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF N/A
Altman-Z -4.29
ROIC/WACCN/A
WACC5.23%
DSS Yearly LT Debt VS Equity VS FCFDSS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

DSS has a Current Ratio of 0.98. This is a bad value and indicates that DSS is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of DSS (0.98) is worse than 74.70% of its industry peers.
A Quick Ratio of 0.94 indicates that DSS may have some problems paying its short term obligations.
DSS's Quick ratio of 0.94 is on the low side compared to the rest of the industry. DSS is outperformed by 68.67% of its industry peers.
Industry RankSector Rank
Current Ratio 0.98
Quick Ratio 0.94
DSS Yearly Current Assets VS Current LiabilitesDSS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

More info and screens

1

3. Growth

3.1 Past

DSS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 42.38%, which is quite impressive.
DSS shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -36.89%.
Measured over the past years, DSS shows a small growth in Revenue. The Revenue has been growing by 4.20% on average per year.
EPS 1Y (TTM)42.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-7.3%
Revenue 1Y (TTM)-36.89%
Revenue growth 3Y-1.98%
Revenue growth 5Y4.2%
Sales Q2Q%-22.77%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
DSS Yearly Revenue VS EstimatesDSS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
DSS Yearly EPS VS EstimatesDSS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300 -400 -500

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

DSS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DSS Price Earnings VS Forward Price EarningsDSS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
DSS Per share dataDSS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 -4 -6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for DSS!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

DSS INC

NYSEARCA:DSS (5/2/2025, 8:04:00 PM)

0.999

+0.02 (+2.39%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)03-25 2025-03-25/bmo
Earnings (Next)05-12 2025-05-12
Inst Owners1.72%
Inst Owner Change0%
Ins Owners30.96%
Ins Owner Change0.63%
Market Cap9.08M
Analysts80
Price TargetN/A
Short Float %0.56%
Short Ratio0.56
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.48
P/FCF N/A
P/OCF N/A
P/B 0.45
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-6.63
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-1.03
FCFYN/A
OCF(TTM)-1
OCFYN/A
SpS2.1
BVpS2.23
TBVpS-0.05
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -44.06%
ROE -231.73%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-40.24%
ROA(5y)-26.07%
ROE(3y)-135.15%
ROE(5y)-84.67%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.18
Health
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 12.19%
Cap/Sales 1.43%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.98
Quick Ratio 0.94
Altman-Z -4.29
F-Score3
WACC5.23%
ROIC/WACCN/A
Cap/Depr(3y)16.53%
Cap/Depr(5y)165.83%
Cap/Sales(3y)3.35%
Cap/Sales(5y)34.38%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)42.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-7.3%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-36.89%
Revenue growth 3Y-1.98%
Revenue growth 5Y4.2%
Sales Q2Q%-22.77%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y19.68%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y53.25%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y52.68%
OCF growth 3YN/A
OCF growth 5YN/A